Clinical Trial Update: A 6 microRNA Tool for Stratifying Stage II Colon Cancer of Receiving Adjuvant Chemotherapy [NA]

View source ↗

Summary

The document reports on a clinical trial evaluating a six-microRNA biomarker tool to help decide whether stage II colon cancer patients should receive adjuvant …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: Colonic Neoplasms, Effects of Chemotherapy | NA | Status: UNKNOWN